Literature DB >> 3566622

A bacteriological study of otitis media with effusion. Concurrent coagulase-negative staphylococcal infections in the middle ear.

T Bunse, H Hildmann, W Zan, W Opferkuch.   

Abstract

We investigated the bacteriology of 50 chronic middle ear effusions from 30 children (mean age, 5 years 4 months) and compared this with the microorganisms present in the external ear canals and adenoids of each patient to distinguish pure middle ear bacteria from probable contaminations. Coagulase-negative staphylococci (CS), formerly considered to be non-pathogens, were the most frequently isolated bacteria in the middle ear effusions and were followed in incidence by alpha-hemolytic streptococci and group D streptococci. CS were found in 24% of all effusions and in 44% of the infected effusions. Most of the CS strains belonged to the species of Staphylococcus epidermidis. Although the majority of CS isolated from the middle ear effusions studied proved not to be contaminants, the populations of CS in the middle ear and external ear canal showed similar biochemical reaction patterns, antimicrobial susceptibilities, and in vitro production of mucus. No correlation was found between the bacteria present in adenoidal tissue and middle ear effusions.

Entities:  

Mesh:

Year:  1987        PMID: 3566622     DOI: 10.1007/bf00464648

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  11 in total

1.  Single-disk antibiotic-sensitivity testing of staphylococci; an analysis of technique and results.

Authors:  A W BAUER; D M PERRY; W M KIRBY
Journal:  AMA Arch Intern Med       Date:  1959-08

2.  The role of coagulase-negative staphylococci in chronic otitis media with effusion.

Authors:  J M Bernstein; D Dryja; E Neter
Journal:  Otolaryngol Head Neck Surg       Date:  1982 Nov-Dec       Impact factor: 3.497

3.  The microbiology of serous and mucoid otitis media.

Authors:  G S Giebink; E L Mills; J S Huff; C K Edelman; M L Weber; S K Juhn; P G Quie
Journal:  Pediatrics       Date:  1979-06       Impact factor: 7.124

4.  A microbiological study of secretory otitis media using an anaerobic technique.

Authors:  S Edström; H Ejnell; F Jörgensen; A Möller
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1985       Impact factor: 1.538

5.  Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response.

Authors:  E D Gray; G Peters; M Verstegen; W E Regelmann
Journal:  Lancet       Date:  1984-02-18       Impact factor: 79.321

Review 6.  Panel discussion: pathogenesis of otitis media. Bacteriology and immunology.

Authors:  D J Lim; T F DeMaria
Journal:  Laryngoscope       Date:  1982-03       Impact factor: 3.325

7.  Panel discussion: pathogenesis of otitis media. Pathology and microbiology of otitis media.

Authors:  W L Meyerhoff; G S Giebink
Journal:  Laryngoscope       Date:  1982-03       Impact factor: 3.325

8.  Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces.

Authors:  G D Christensen; W A Simpson; A L Bisno; E H Beachey
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

9.  Bacteria in the middle ear and ear canal of patients with secretory otitis media and with non-inflamed ears.

Authors:  P Sipilä; A M Jokipii; L Jokipii; P Karma
Journal:  Acta Otolaryngol       Date:  1981 Jul-Aug       Impact factor: 1.494

10.  Role of anaerobes in chronic otitis media.

Authors:  G G Browning; G Picozzi; G Sweeney; I T Calder
Journal:  Clin Otolaryngol Allied Sci       Date:  1983-02
View more
  2 in total

1.  An immunological study of otitis media with effusion. Antibodies directed against coagulase-negative staphylococci in the effusion fluid.

Authors:  T Bunse; H Hildmann; W Zan; W Opferkuch
Journal:  Arch Otorhinolaryngol       Date:  1987

2.  Mutation in Phex gene predisposes BALB/c-Phex(Hyp-Duk)/Y mice to otitis media.

Authors:  Fengchan Han; Heping Yu; Ping Li; Jiangping Zhang; Cong Tian; Hongbo Li; Qing Yin Zheng
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.